I say this is a duck-calm on the surface, feet going furiously below water. Gold price is retarding it. Cash flow will put paid to undervaluations. Further it is competitive on capital intensity.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025